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The pituitary is a complex gland comprising different cell types each secreting specific hormones.
The extensive network of signaling molecules and transcription factors required for determina-
tion and terminal differentiation of specific cell types is still not fully understood. The SRY-like
HMG-box (SOX) transcription factor Sox4 plays important roles in many developmental processes
and has two homologs in zebrafish, Sox4a and Sox4b. We show that the sox4b gene is expressed
in the pituitary anlagen starting at 24 h after fertilization (hpf) and later in the entire head region
including the pituitary. At 48 hpf, sox4b mRNA colocalizes with that for TSH (tsh), glycoprotein
subunit  (gsu), and the Zn finger transcription factor Gata2a. Loss of Sox4b function, using
morpholino knockdown or expression of a dominant-negative Sox4 mutant, leads to a drastic
decrease in tsh and gsu expression and reduced levels of gh, whereas other anterior pituitary
gland markers including prl, sl, pomc, and lim3 are not affected. Sox4b is also required for
expression of gata2a in the pituitary. Knockdown of gata2a leads to decreased tsh and gsu
expression at 48 hpf, similar to sox4bmorphants. Injection of gata2amRNA into sox4bmorphants
rescued tsh and gsu expression in thyrotrope cells. Finally, sox4b or gata2a knockdown causes
a significant decrease of gonadotropin expression (lh and fsh) at 4 d after fertilization. In
summary, our results indicate that Sox4b is expressed in zebrafish during pituitary development and
plays a crucial role in the differentiation of thyrotrope and gonadotrope cells through induction of
gata2a expression in the developing pituitary. (Molecular Endocrinology 26: 1014–1027, 2012)
In the last decades, knowledge concerning developmentof the pituitary gland has been gained from identifica-
tion of genes involved in human congenital pituitary hor-
mone deficiency, a pathology characterized by hypopitu-
itarism (1). Also, spontaneous mutations and reverse
genetics in murine models revealed that normal anterior
pituitary formation is dependent upon a complex genetic
cascade of signaling molecules and transcription factors
(1–3).More recently, studies in mammals have been com-
plemented by those in zebrafish that might prove useful to
uncover thus far unidentified mechanisms and regulators
of pituitary development and to better understand the
evolution of this important gland.
The basic mechanisms of anterior pituitary develop-
ment appear to be conserved between fish and mammals.
The mature gland is formed of several cell types, each
secreting a specific hormone (4): somatotropes producing
GH, lactotropes secreting prolactin (Prl), thyrotropes
synthesizing TSH, and gonadotropes producing LH and
FSH. The glycoprotein -subunit (Gsu) is expressed in
thyrotropes and gonadotropes, where it associates respec-
tively with Tsh or Lh and Fsh. ACTH andMSH, both
proteolytically cleaved from the same precursor proopio-
melanocortin, are secreted by, respectively, corticotropes
ISSN Print 0888-8809 ISSN Online 1944-9917
Printed in U.S.A.
Copyright © 2012 by The Endocrine Society
doi: 10.1210/me.2011-1319 Received November 11, 2011. Accepted March 30, 2012.
* Y.Q. and M.L. contributed equally to this manuscript.
Abbreviations: BMP, Bone morphogenetic protein; coMO, control morpholino; dpf, days
after fertilization; Gsu, glycoprotein -subunit; hpf, hours after fertilization; KO, knock-
out; MO, morpholino; PPE, preplacodal ectoderm; qRT-PCR, quantitative real-time RT-
PCR; Prl, prolactin; SOX, SRY-related HMG box; WISH, whole-mount in situ hybridization;
wt, wild type.
O R I G I N A L R E S E A R C H
1014 mend.endojournals.org Mol Endocrinol, June 2012, 26(6):1014–1027
 Molecular Endocrinology. First published ahead of print April 27, 2012 as doi:10.1210/me.2011-1319
Copyright (C) 2012 by The Endocrine Society 
and melanotropes. An additional pituitary hormone is
present in teleosts, somatolactin, closely related to Prl and
Gh. Two sl genes have been identified in zebrafish that are
expressed in specific domains of the adult gland (5). One
of them, sl, was shown to be expressed in wild-type (wt)
zebrafish from 23 h after fertilization (hpf) onward (6).
Like in other vertebrates, the initial steps of zebrafish
anterior pituitary formation start when gastrulation is
completed at approximately 10 hpf. Specific transcription
factors gradually restrict pituitary cell development and
promote their differentiation into specific cell types. At
this phase of development, the neural plate is bordered
caudally by the neural crest and rostrally by the prepla-
codal ectoderm (PPE). Hedgehog signaling from the ven-
tral forebrain specifies the median region of the PPE to
form the pituitary placode (7). At this early stage, the PPE
is characterized by the expression of multiple marker
genes, such as eyes absent (eya1) and sine oculis (six1) (8),
the bicoid-related paired-like homeobox gene pitx3 or the
dlx3b gene (7, 9). The first anterior pituitary-specific
marker to come up during the mid-segmentation stage
(18–20 hpf) is the Lim-domain homeobox gene lim3,
which is expressed in all anterior pituitary precursor cells.
Another early marker is the POU domain homeobox fac-
tor Pit1 (10, 11). In contrast to the pan-pituitary marker
lim3, pit1 is activated in just a subset of anterior pituitary
cells. In mouse, loss of Pit1 function leads to absence of
gh- and prl-expressing cells and a trans-fating of thyro-
tropes to gonadotropes (10, 11). Zebrafish pit1 mutants
appear to display a similar thyrotrope to gonadotrope
trans-fating (11). Another factor specifically involved in
thyrotrope and gonadotrope formation in the mouse is
the Zn-finger transcription factor Gata2 (12). During
normal thyrotrope development, Pit1 attenuates expres-
sion of the lh gene by binding and blocking the tran-
scription factor Gata2 (12).
Transcription factors of the SRY-related HMG box
(SOX) family are characterized by the presence of a highly
conserved, DNA-binding HMG box domain. These fac-
tors are widely and dynamically expressed throughout
embryogenesis and have been implicated in many devel-
opmental processes (13) ranging from early cell fate de-
termination (14) to control of lens development (15–17)
or chondrogenesis (18–20). Sox3 was the first member of
this family to be associated with X-linked hypopituitar-
ism in mice and humans (21, 22). It is expressed in the
ventral diencephalon and in the infundibulum, adjacent
to theRathke’s pouch, but not in the presumptive anterior
pituitary (21–23). Sox2 was similarly found to be critical
for the development of the hypothalamo-pituitary axis by
maintaining a pool of undifferentiated cells in the pitu-
itary (24, 25).
Sox4 is a member of the group C Sox proteins that
contains a C-terminal transcription activation domain
conserved within this group and has been involved in the
development of various structures (26–30). Two Sox4
homologs are present in zebrafish, but only sox4b was
shown to be expressed in pancreas and required for dif-
ferentiation of glucagon-expressing cells (31), similar to
the function of Sox4 in normal development of pancreatic
islets in mouse (32). Recently, SOX4 was found to be one
of the main transcription factors expressed in fetal pitu-
itary in human (33). However, its function in the pituitary
has not been investigated so far.
Here, we investigate the function of the zebrafish Sox4
homolog, Sox4b, in pituitary development.We show that
sox4b is specifically expressed in the anterior pituitary
primordium at 24 and 48 hpf, more specifically in gsu-,
gata2a- and tsh-expressing cells. We show that sox4b is
required for the differentiation of thyrotrope and gonado-
trope cells, and finally, we demonstrate that gata2a ex-
pression is regulated by Sox4b in developing zebrafish
pituitary.
Materials and Methods
Zebrafish maintenance, mutant lines, and
microinjection
Zebrafish (Danio rerio) were maintained under standard
conditions (34) in the GIGA-R zebrafish facility. Wild-type em-
bryos from the AB strainwere produced and staged according to
Kimmel et al. (35). The pit1mutant was previously described (8,
11, 36).
Antisense morpholinos (MO) (Gene Tools, Philomath, OR)
were used. Standard control MO (coMO) 5-CCTCTTACCT-
CAGTTACAATTTATA-3 is known to have no target and no
significant biological activity in zebrafish embryos; sox4bMO 5-
GACTCAGTCTGATTGCACACAGTCC-3 and sox4bMO2 5-
TGCTGCTGGATCTCTGGAGCAT-3, targeting the 5-untrans-
lated region of sox4b or the first 25 bases of the coding sequence,
respectively, to block translation, were previously described (31)
and were injected at an optimal dose of 7 ng/egg or 2 ng/egg,
respectively; and gata2aMO 5-CATCTACTCACCAGTCT-
GCGCTTTG-3 is a splice blocking MO targeting the third exon/
intron boundary of the gata2a gene (30) and was used at a dose of
0.5 ng/egg.
The mRNA coding for the dominant-negative mutant
Sox4bC (37) or enhanced green fluorescent protein was in-
jected at 0.2 ng/egg. To perform phenotypic rescue experiments,
gata2amRNAwas synthesized and then injected into sox4b- or
gata2aMO-injected or wt embryos at concentrations of 100 and
75 pg, respectively. MO were diluted in Danieau’s buffer con-
taining 0.5% rhodamine-dextran for checking the injection.
Microinjection was performed at the one-cell stage; the in-
jected embryos were fixed at different stages in 4% paraformal-
dehyde and stored in 100% methanol before analysis.
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Riboprobes and whole-mount in situ hybridization
(WISH)
Single and double whole-mount and double-fluorescent in
situ hybridizations were performed as previously described (37,
38) on wt and mutant embryos. Antisense RNA probes were
prepared by transcribing linearized cDNA clones with SP6, T7,
or T3 polymerase using digoxigenin labeling mix (Roche, Indi-
anapolis, IN) or DNP-11-UTP ribonucleotides (TSAi Plus sys-
tem; PerkinElmer, Norwalk, CT). The riboprobes used were
lim3, gata2a, pit1, prl, gsu, tsh, gh and sl (6, 11, 39–41) as
described. The lh cDNA (438 bp) (accession no. HE608243)
covering the partial coding region was obtained by performing
RT-PCR on mRNA from 5-d-old [days after fertilization (dpf)]
zebrafish larvae using the primers zfLHBfor3 (cagcctgctgag-
caac) and zfLHBrev1 (cctctctctgggacatgcagaag) and contained
three silent mutations relative to the reference lh sequence.
Fluorescence imaging
For confocal analysis, images were acquired using a Leica
TCS SP2 inverted confocal laser microscope (Leica Microsys-
tems, Heidelberg, Germany) equipped with one argon and two
helium-neon lasers. Digitized images were acquired using a10
(NA 0.4) or 63 (NA 1.4) Plan-Apo water-immersion objec-
tives at 1024-  1024-pixel resolution. The diameter of the
pinhole was set up equal to the Airy unit. Series of optical sec-
tions were carried out to analyze the spatial distribution of flu-
orescence, and for each embryo, they were recorded with a
Z-step ranging set to 2.0 m. Images were acquired under iden-
tical conditions, and we ensured that the maximal fluorescence
signal was not saturating the photomultiplier tubes. For multi-
color imaging, fluorescein isothiocyanate was visualized by using
an excitation wavelength of 488 nm, and the emission light was
dispersed and recorded at 500–535nm.Cy3was detected by using
an excitation wavelength of 543 nm and the 488/543 dichroic
mirror, and the emission light was dispersed and recorded at 595–
650 nm. The acquisition was set up to avoid any cross talk of the
two fluorescence emissions. Captured images were exported as
TIFF format files and further processed using Adobe Photoshop.
RNA extraction and reverse transcription
Total RNA was extracted from about 100 larvae per exper-
iment using the RNeasy Mini kit (QIAGEN, Hilden, Germany)
according to the manufacturer’s instructions. After extraction,
the quality and concentration of total RNA was evaluated by
electrophoresis on capillary gel and the ratio of absorbance at
260/280 nm by spectrophotometer. Synthesis of cDNAwas per-
formed from 1 g total RNA, which was reverse transcribed
using the transcriptor iScript cDNA synthesis kit (Bio-Rad,Naz-
areth, Belgium) according to the manufacturer’s instructions.
Real-time PCR
Gene-specific oligonucleotide primers were developed using
the Primer3 software and selected so as to span exon-exon junc-
tions to avoid detection of genomic DNA (see Table 1 for prim-
ers used in quantitative RT-PCR) and synthesized by Eurogen-
tec (Seraing, Belgium).
Real-time PCR was performed on an ABI Prism 7000 se-
quence detection system (Applied Biosystems, Foster City, CA)
with SYBR green fluorescent label. Samples (25l final volume)
contained the following: 1 SYBR green master mix (Diag-
enode, Liège, Belgium), 150 nmol of each primer, and 1l of the
reverse transcription reaction (1/20 of the total cDNA). Samples
were run in duplicate in optically clear 96-well plates (ABgene,
Epsom, UK). Cycling parameters were 50 C for 2 min, 95 C for
10min, and then 40 cycles of 95 C for 15 sec and 60C for 1min.
A melting temperature-determining dissociation step was per-
formed at 95 C for 15 sec, 60 C for 15 sec, and 95 C for15 sec
at the end of the amplification phase. For analysis by endpoint
PCR, the final products of the quantitative real-time RT-PCR
(qRT-PCR) obtained after 40 PCR cycles were loaded on aga-
rose gel for electrophoresis.
For the test of gonadotropin expression (lh and fsh), ther-
mal cycling was performed on an Applied Biosystems 7900 HT
sequences detection system. The cDNA was used for qRT-PCR
with the SensiMix SYBR Kit (Bioline, London, UK), containing
SYBR green. The standard conditions were used with a modifi-
cation in the elongation step: 62C for 20 sec for lh and 62C for
30 sec for fsh were used.
No-template controls were run for all reactions, and all RNA
preparations were subjected to sham reverse transcription to
check for the absence of genomic DNA amplification. The rel-
ative transcript level of each gene was obtained by the 2Ct
method (42) and normalized relative to the housekeeping gene
elongation factor1 (ef1) with the program SDS version 2.2.
Results are presented as percent expression in MO-injected em-
bryos relative to clutchmate control embryos  SD.
Statistical analysis
Statistical analysis was performed on raw data using one-
way ANOVA. Significance was set at P  0.01. Data from
biological replicates were averaged and shown as mean normal-
ized gene expression  SD.
TABLE 1. List of primers used for RT-PCR
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Results
Sox4b is expressed in the developing anterior pituitary
The expression pattern of sox4bmRNA in developing
pituitary was determined by WISH experiments in ze-
brafish embryos. Starting at 24 hpf, sox4b mRNA was
detected in the anterior border of the neural plate, corre-
sponding to the early pituitary placode (Fig. 1A). At 26
hpf, sox4b expression is increased in the adjacent ventral
FIG. 1. sox4b is expressed in the pituitary during zebrafish organogenesis. WISH was performed on wt zebrafish embryos using the sox4b
antisense probe. A–C, Lateral views (anterior to the left, dorsal to the top) of wt embryos labeled with the sox4b probe (blue) by WISH. The
arrowheads indicate the pituitary placode at 24 (A), 26 (B), and 48 (C) hpf, respectively. D–F and H–J, Analysis by double-fluorescent WISH
(anterior to the left), with one z-plane of the confocal images shown; D–F, expression of sox4b (red, E) and the pan-adenohypophyseal marker
lim3 (green, D) colocalize in the pituitary placode (F); G, fluorescence emission quantification in F; H–J, sox4b (green, H) and tsh (red, I) are
coexpressed in a subtype of pituitary cells (J); K, fluorescence emission quantification in J. In D–F and H–J, the ventral head regions were dissected
before confocal microscopy. L and M, sox4b expression does not require pit1 at 24 hpf. Analysis of sox4b expression by WISH in wt and
homozygous pit1 mutants. Lateral view, anterior to the left, the arrow indicates the label in the pituitary. Scale bars, 100 m (A, B, C, L, and M)
and 20 m (D–J). D, Diencephalon; M, mesencephalon; My, myencephalon; Tel, telencephalon.
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diencephalon and predominant in the telencephalon (Fig.
1B), although at later stages (48 hpf), sox4b mRNA is
detected in broad regions of the developing forebrain and
midbrain and in a subpopulation of cells in the developing
anterior pituitary (Fig. 1C). Double-fluorescent in situ
hybridizations analyzed by confocal microscopy revealed
that sox4b-positive cells in the ventral neural layer also
express the pituitary precursor marker lim3 at 30 hpf,
confirming that they are located in the anterior pituitary
primordium (Fig. 1, D–G). Finally, at 48 hpf, a clear co-
localization of sox4b mRNA was observed with tsh
mRNA (Fig. 1, H–K), suggesting that sox4b is expressed
in thyrotrope cells.
Sox4b expression was also assessed in the previously
described pituitary mutant pit1 (8, 11, 36). Sox4bmRNA
was readily detected in pituitaries of pit1mutant embryos
similar to their heterozygous or wt siblings at 24 hpf (Fig.
1, L and M).
Knockdown of Sox4b eliminates expression of
tsh and gsu in the pituitary
To investigate the function of Sox4b in pituitary devel-
opment, wemicroinjected antisenseMOoligonucleotides
to ablate sox4b expression as previously described (31)
and analyzed specific gene expression by WISH and by
qRT-PCR in 48-hpf embryos. Control experiments
checking pancreatic markers in the injected embryos con-
firmed the previously observed effect on glucagon expres-
sion (31) (Table 2). When the presence of the various
pituitary hormone mRNA was investigated in these mor-
phants (summarized in Table 2), we observed a drastic
reduction of tsh expression in sox4bMO-injected em-
bryos at 48 hpf (Fig. 2, A andD). Similarly, the expression
of gsuwas specifically reduced in sox4bmorphants (Fig.
2, B and E), indicating that the two hormone subunits
specific to thyrotrope cells are no longer expressed in
these embryos. gh expression was reduced in 83% of the
sox4bMO-injected embryos (Fig. 2, C and F), whereas
sl, prl, and pomc (Fig. 2, G–L) did not seem to be af-
fected. Expression of gh, tsh, and gsu was also absent
in 4-dpf sox4b morphants (Table 2) and in 48-hpf em-
bryos previously injected with a different MO
(sox4bMO2) against sox4b (Table 3). To confirm these
results observed by in situ hybridization, qRT-PCR were
performed using mRNA extracted from microinjected
48-hpf morphants and control embryos. The results con-
firmed the strong down-regulation of tsh, gsu, and gh
expression (Fig. 3), whereas prl, the widely expressed
lim3 factor (see also below) or the control mRNA ef1
(elongation factor 1) were not affected.
To confirm the specificity of the effects observed by
MO injection, we abolished Sox4b function by microin-
jecting an mRNA coding for a Sox4b dominant-negative
mutant, lacking its transactivation domain (sox4bC)
(31). Injection of sox4bC mRNA into wt embryos also
resulted in a decrease of gsu, tsh, and gh expression,
whereas prl is not affected (Fig. 4), thus confirming the
specificity of the defects observed upon MO injection.
In conclusion, our results indicate that sox4b knock-
down specifically affects expression and differentiation of
thyrotrope and somatotrope cells.
TABLE 2. Sox4b regulates expression of tsh, gsu, and lh in zebrafish
NI normal coMO normal sox4bMO absence sox4bMO decrease
Embryo, 48 hpf
tsh 10/10 89/100 12/122 110/122a
gsu 10/10 38/40 0/38 38/38a
glucagon 10/10 70/78 0/78 78/78a
sl 8/10 38/40 5/40 0/40
pomc 10/10 40/40 0/40 0/40
lim3 10/10 38/38 2/40 0/40
pit1 10/10 27/27 0/35 0/35
gata2a 10/10 40/40 38/40a 0/40
gh 9/10 45/45 0/58 48/58a
prl 10/10 50/50 0/50 0/50
Larvae, 4 dpf
lh 10/10 50/50 0/50 28/50
tsh 10/10 50/50 12/50a 15/50a
gsu 10/10 50/50 0/50 30/50a
gh 10/10 50/50 0/50 25/50a
prl 10/10 50/50 0/50 0/50
Individual embryos, previously noninjected (NI) or injected with coMO or sox4bMO, were optically analyzed and compared for expression of
different marker genes at 48 hpf and 4 dpf. The embryos were classified according to phenotype, and the number of each class is given relative to
the total number of analyzed embryos for each condition. Absence indicates lost expression; decrease indicates that marker expression was
reduced by more than 50%.
a Significant at P  0.001.
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Sox4b is required for the expression of gata2a
specifically in the pituitary
To shed some light on the molecular mechanisms
involved in Sox4b function in the pituitary, we tested
for the expression of known transcription factors in
sox4b morphants. The pan-pituitary marker lim3 was
not affected upon sox4b knockdown (Fig. 5, A and D,
and Table 2). One of the factors required for thyro-
trope differentiation is the pituitary-specific, POU-ho-
meodomain factor Pit1 (10). Zebrafish pit1 mutants
were shown to be deficient in prl, gh, sl, and tsh
expression (6, 11). At 48 hpf, sox4bMO-injected em-
TABLE 3. Individual embryos, injected with coMO or sox4bMO2, were optically analyzed and compared as in Table
1 at 48 hpf
Embryos, 48 hpf coMo 2 ng normal sox4bMO2 2 ng absence sox4bMO2 2 ng decrease
gsu 25/25 5/25a 20/25a
tsh 25/25 0/20 20/25a
gh 25/25 15/25a 10/25a
prl 25/25 0/25 0/25
a Significant at P  0.001.
FIG. 2. sox4b knockdown decreases tsh, gsu, and gh expression in 48-hpf embryos. Fertilized eggs were microinjected with sox4bMO and
analyzed by WISH for pituitary hormone expression. A–C and G–I, Control embryos; D–F and J–L, sox4b morphants, ventral views (anterior to the
top); both tsh (D) and gsu (E) expression is almost completely lost, whereas gh expression is decreased (F) and sl, prl, and pomc are unchanged
(J–L). Scale bars, 50 m (A–L).
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bryos displayed unaltered pit1 expression in a frontal
view (Fig. 5, B and E).
Another factor specifically involved in pituitary thyro-
trope formation in mouse is the Zn-finger transcription
factor Gata2 (12, 43). Although gata2a is widely ex-
pressed in the head region of the developing embryos at
48 hpf, we could clearly observe that its weak expression
in the pituitary of coMO-injected embryos was com-
pletely absent in sox4b morphants (Fig. 5, C and F). Al-
though qRT-PCR cannot directly assess the amount of gata2a
or lim3expression in thepituitarydue to theirwiderexpression
in the head region, it is noteworthy that the overall amount of
gata2a and lim3mRNAwas unchanged (or slightly increased)
in the sox4bmorphants (Fig. 3).
In conclusion, our data indicate that sox4b knock-
down specifically affects the expression of gata2a in the
developing pituitary and blocks differ-
entiation of thyrotrope cells.
Sox4b and gata2a are specifically
coexpressed in the anterior
pituitary
Expression of gata2a was clearly
observed in the pituitary at 48 hpf (Fig.
6A). Relative to the pomc-expressing
corticotropes (Fig. 6B) and the prl-ex-
pressing lactotropes (Fig. 6C) located
at the anterior border of the pituitary,
gata2a-expressing cells are detected in
a posterior domain. Double-fluores-
cent in situ hybridization revealed that
gata2a is clearly coexpressedwith gsu
(Fig. 6, D–G). Similarly, gata2amRNA
is colocalized with sox4bmRNA (Fig. 6, H–K) and is also
present in tsh-expressing cells, whereas some gata2a-
positive cells did not express tsh (Fig. 6, L–N), probably
representing gonadotrope precursor cells. No colocaliza-
tion was observed between gata2a and ghmRNA (Fig. 6,
O–Q).
Expression of gata2a was also tested by double in situ
hybridization in the previously described pit1 mutant
(8, 11, 36). We observed that expression of gata2a was
similar to wt or heterozygous siblings at 48 hpf (Fig. 6,
R and S).
Depletion of gata2a leads to loss of thyrotrope
cells
To compare the effects of gata2a and sox4b depletion
in developing embryos, wemicroinjected gata2aMO(37)
FIG. 3. qRT-PCR analysis of mRNA extracted from control and sox4b morphants. Total RNA
was extracted from 48-hpf embryos injected with coMO or sox4bMO, and specific mRNA
levels were determined by qRT-PCR. mRNA levels in control embryos were arbitrarily set to 100 for
each primer pair and shown as mean relative levels SE. The results shown are representative of
three independent experiments for each mRNA. ***, Significant at P 0.001.
FIG. 4. Expression of the dominant-negative Sox4bC mutant decreases thyrotrope gene expression. sox4bC mRNA or egfp mRNA was
microinjected into fertilized eggs, and WISH experiments were performed to detect gsu (A and E), tsh (B and F), gh (C and G), or prl (D and H)
expression at 48 hpf. Ventral views (anterior to the top) are shown. Scale bar, 50 m. Arrowheads in E–G point to the decreased expression in
thyrotrope cells.
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into fertilized eggs and analyzed hormone expression in
48-hpf embryos. Expression of tsh and gsu were
drastically reduced in gata2a morphants relative to
control MO-injected embryos (Fig. 7, A, B, E, and F),
whereas prl expression was not affected (Fig. 7, I and J)
at 48 hpf. When we coinjected mRNA coding for
gata2a together with gata2a MO, expression of both
tsh and gsu was clearly rescued (Fig. 7, C and G),
whereas injection of gata2a mRNA alone had no effect
(Fig. 7, D and H).
Collectively, our results show that the defects due to
gata2a depletion are very similar to those in sox4b mor-
phants, suggesting that the two factors are components of
a common pathway.
Exogenous Gata2a rescues Sox4b depletion in the
pituitary
To understand the relationship between Gata2a and
Sox4b in the regulatory pathways, we next askedwhether
ectopic expression of gata2a could restore expression in
sox4b-depleted embryos.
Injection of sox4bMO resulted in a decrease of tsh
and gsu expression, as expected, whereas coinjection of
gata2a mRNA together with sox4bMO completely re-
stored this expression at 48 hpf (Fig. 8).
Taken together, our results demonstrate that the pres-
ence of Sox4b is required for gata2a expression in the
pituitary, which itself is required for thyrotrope
differentiation.
Sox4b and gata2a are both involved in the
expression of gonadotropins (fsh and lh) in the
zebrafish developing pituitary
Gata2 is known in mouse to be required for expression
of gonadotropins, whereas our own results show that
both Gata2a and Sox4b control expression at 48 hpf of
gsu, the hormone subunit common to thyrotropes and
gonadotropes. Consequently, we considered the possibil-
ity that both transcription factors might play a role also in
gonadotropin expression.
Previous studies suggested that fsh and lh transcript
levels in the larval zebrafish pituitary are extremely low
and detectable only via RT-PCR at 72 hpf (8). There-
fore, we first tested the gonadotropin -subunit mRNA
levels by qRT-PCR in RNA extracted from 4-dpf larvae
previously microinjected with control MO or MO di-
rected against sox4b or gata2a. The results show that in
sox4b morphants (Fig. 9A) and in gata2a morphants
(Fig. 9B), both lh and fsh mRNA levels are clearly
decreased relative to control MO-injected larvae.
When we analyzed lh expression by fluorescent in situ
hybridization in 4-dpf larvae, we could clearly detect
several lh-expressing cells in the controls, whereas no
or only weakly labeled cells were detected in sox4b
morphants (Fig. 9C). As an internal control for the
efficiency of in situ hybridization and detection, we
used in parallel a probe for the pancreatic marker in-
sulin (ins), whose signal was not affected by sox4bMO
injection.
FIG. 5. sox4b knockdown leads to decreased expression of gata2a. Fertilized eggs were microinjected with sox4bMO and analyzed by WISH for
expression of lim3 and pit1 or by single fluorescent whole-mount in situ hybridization for gata2a (red) in the embryos at 48 hpf. A–C, Control; D–
F, sox4bMO-injected embryos; A and D, ventral view (anterior to the top) (scale bar, 100 m); B and E, ventral view (anterior to the top) (scale bar,
50 m); C and F, z-plane confocal image lateral view (anterior to the left) (scale bar, 60 m). Arrowheads in C and F point at the position of
gata2a expression in the pituitary.
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Taken together, these results show that Sox4b and
Gata2a are both required for gonadotropin expression in
zebrafish pituitary.
Discussion
The Sox4 transcription factor is highly conserved in ver-
tebrates, encoded by a single exon, and expressed in dif-
ferent tissues during embryonic and adult life. In mam-
mals, Sox4 is essential for heart, lymphocyte, and
thymocyte development (44). Furthermore, Sox4 was
shown to be required for normal endocrine pancreas de-
velopment inmouse (32). Recently, SOX4 expressionwas
found in the human fetal pituitary (33).
In zebrafish, two homologs for the mammalian Sox4
gene exist, only one of them, sox4b, was shown to be
required for glucagon-producing cell differentiation (31).
In our study, we determined the expression and func-
tional role of Sox4b in the specification of endocrine cell
types during anterior pituitary development in zebrafish.
We observed sox4b-expressing cells in a domain lo-
cated in the pituitary placode at early stages (24 hpf) and
in the directly adjacent ventral diencephalon. At 30 hpf,
sox4b expression covers most of the lim3-expressing do-
main (Fig. 1), confirming that sox4b is expressed in pitu-
itary precursor cells. At later stages (48 hpf), sox4b
mRNA is detected in the entire forebrain, and a clear
signal is detected in the pituitary region expressing tsh
(Fig. 1), gsu, and the transcription factor gata2a. All
these observations confirm that Sox4b is expressed in
pituitary cells in zebrafish, consistent with its recently
described expression in human fetal pituitary (33).
Loss-of-function studies using MO knockdown or ex-
pression of a dominant-negative Sox4 mutant allowed us
to uncover a key role for Sox4b in pituitary cell fate spec-
ification. Loss of Sox4b function results in dramatic re-
duction of gsu, tsh, lh, and fsh expression and a
moderate decrease in gh expression, whereas other pitu-
itary markers are not significantly affected at 48 hpf, in-
dicating that sox4b expression is mainly required for dif-
ferentiation of the specific gsu-expressing lineage giving
rise to thyrotrope and gonadotrope cells during pituitary
development.
Sox4b does not affect expression of the pituitary tran-
scription factors Pit1 and Lim3; however, it is required for
expression of the zinc finger transcription factor Gata2a
specifically in the zebrafish developing pituitary. The
function of Gata2 was intensely studied in the hemato-
poietic tissues for proliferation and survival of hemato-
poietic stem cells (45). A function in urogenital develop-
ment (46) and in adipocyte (47) and endothelial cell (48)
FIG. 6. gata2a mRNA is detected in sox4b- and gsu-expressing cells in
48-hpf embryos. WISH was performed on wt zebrafish embryos using the
gata2a antisense probe. A and C, Lateral view (anterior to the left); B,
ventral view (anterior to the top). Scale bars, 100 m (A), 45 m (B), and
40 m (C). Arrowhead in A points at gata2a expression in the pituitary. A,
Single-probe gata2a (blue); B, double-fluorescent WISH showing gata2a
(green) and pomc (red) mRNA (z-plane confocal image); C, double WISH
showing gata2a (blue) and prl (red) mRNA; the ventral head regions were
dissected before microscopy. D–N, Double-fluorescent WISH showing
coexpression as follows: D-G, of gata2a (green, D) and gsu (red, E); F,
overlay of D and E; G, fluorescence emission quantification in F. H-K,
sox4b (green, H) and gata2a (red, I); J, overlay of H and I; K, fluorescence
emission quantification in J. L–N, tsh (green, L) and gata2a (red, M); N,
overlay of tsh and gata2a expression; D–N, z-plane confocal image,
ventral views (anterior to the left). O–Q, Z-plane of the confocal images,
lateral view (anterior to the left); gata2a (red, O) and gh (green, P); Q,
overlay of gata2a and gh expression. R and S, gata2a expression in wt and
pit1mutants (pit1-/-) are shown in upper right corner in embryos at 48
hpf. Analysis by double-fluorescent WISH, lateral view (anterior to the
left), one Z-plane of the confocal images is shown; gata2a (green, R and
S) and prl (red, R) is shown, the arrowhead points to gata2a expression in
the pituitary (R and S). Scale bars, 40 m (D–F, L–N, R, and S), 20 m (H–
J), and 60 m (O–Q).
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differentiation was also described. In mouse, Gata2 ex-
pression was shown in thyrotropes and gonadotropes
starting at embryonic day 10.5 (12) and transfection stud-
ies in cell cultures revealed that Gata2 activates the Tsh
promoter through a synergistic action with Pit1 in thyro-
tropes (49). Gata factors also stimulate theGsu promo-
tor in mouse gonadotrope cells (50). Recently, a mouse
Cre-Lox knockout (KO) model was generated where
Gata2 gene disruption specifically in Gsu-expressing
cells decreased the number of thyrotropes and gonado-
tropes at birth and severely reduced Tsh, Lh, and Fsh
expression in the adult (43).
In zebrafish, gata2a transcripts are detected in the ven-
tral ectoderm at 75% epiboly and in the yolk syncytial
FIG. 8. Expression of exogenous Gata2a rescues the pituitary defects in sox4b morphants. WISH analysis was performed for expression of tsh
and gsu in 48-hpf embryos previously microinjected with coMO (A and E), sox4bMO (B and F), sox4bMO and gata2a mRNA (C and G), or coMO
and gata2a mRNA (D and H). A–H, Ventral views (anterior to the top). Scale bar, 50 m.
FIG. 7. Thyrotrope expression depends on gata2a expression. WISH analysis for expression of tsh, gsu, and prl in 48-hpf embryos previously
microinjected with (A, E, and I) coMO; (B, F, and J) gata2aMO, (C, G, and K) gata2aMO and gata2a mRNA or (D, H, and L) coMO and gata2a
mRNA. A–L, Ventral views (anterior to the top). Scale bar, 50 m.
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layer at 90% epiboly (39); later, it is expressed in hema-
topoietic tissues and the central nervous system (51). Sim-
ilar to mouse, Gata2a can modify the expression of spe-
cific genes in erythrocytes (37). In the developing
pituitary, we found gata2a expression to be highly over-
lapping with that of sox4b and gsu, indicating a close
relationship between gata2a and the gsu cell lineage.We
also found that gata2a is expressed in all tsh-expressing
cells at 48 hpf.Whenwe investigated hormone expression
in gata2a morphants, we indeed observed a drastic de-
crease of tsh and gsu expression at 48 hpf and of go-
nadotropins at 4 dpf. These results are consistent with
those previously described in the conditional KO mouse
model (43). However, the defects observed in zebrafish
appear to bemuch stronger than those reported inmouse;
the number of thyrotrope and gonado-
trope cells was lower at birth but recov-
ered in the adult, whereas Tsh, Lh, and
Fsh expression remained severely re-
duced in the adult. Thus, in the mouse
pituitary, Gata2 appears to be dispens-
able for initial gonadotrope and thyro-
trope cell fate determination but im-
portant for expansion of the cell
lineage during embryogenesis and for
optimal gonadotrope and thyrotrope
function in the adult. Unfortunately,
no data are available concerning Tsh,
Lh, and Fsh expression at early
stages of the conditional KOmouse pi-
tuitary development; thus, it remains
unclear whether theGata2 depletion in
mouse leads to a drastic delay of thy-
rotrope and gonadotrope differentia-
tion or whether the recovery in cell
number results from a compensatory
mechanism, such as the reported up-
regulation of Gata3 expression in
Gata2-deficient mice (43).
Interestingly, the sox4b and gata2a
genes in zebrafish display similar char-
acteristics; both are coexpressed in the
same pituitary precursor cells also ex-
pressing gsu, and both are involved in
thyrotrope and gonadotrope differen-
tiation. We further showed that sox4b
knockdown led to decreased expres-
sion of gata2a in the pituitary, suggest-
ing that Sox4b activates gata2a expres-
sion. We confirmed this hypothesis by
demonstrating that exogenous Gata2a
expression can compensate for the lack
of Sox4b function in tsh and gsu cell differentiation in
sox4b morphants. Our in situ experiments show that
sox4b is expressed at later stages (48 hpf) in the hypothal-
amus of the developing zebrafish; thus, an indirect effect
of hypothalamic signaling on pituitary gata2 expression
can be envisaged. However, although we cannot com-
pletely rule out a role of hypothalamic Sox4b, the perfect
coexpression of sox4b and gata2a in gsu-expressing
cells argues in favor of a cell-autonomous regulation of
gata2a expression by the Sox4b transcription factor.
We show that the expression of the pan-pituitary
marker lim3 is unchanged in sox4b knockdown embryos,
indicating that the number of pituitary-specified cells re-
mains unaltered, whereas their capacity to terminally dif-
ferentiate is affected. Furthermore, thyrotrope cells de-
FIG. 9. Both Sox4b and Gata2a are required for gonadotropin expression. Expression of lh
and fsh was measured by qRT-PCR in RNA extracted from sox4b morphant (A) and gata2a
morphant (B) larvae of 4 dpf. The data were normalized relative to the ef1 transcript, and
the levels in coMO-injected embryos were arbitrarily set to 1. Mean fold change relative to
control morphants is shown with the corresponding SD (n  3). ***, Significant at P  0,001.
The results shown are representative of three independent experiments. C, Analysis by
double-fluorescent WISH for expression of lh and ins at 4 dpf previously microinjected with
coMO or sox4bMO; pancreatic ins (arrowhead) expression was assessed as invariant control.
C, Ventral view (anterior to the left). Scale bar, 200 m.
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pend on the transcription factor Pit1 for their
differentiation. Our results clearly show that pit1 expres-
sion is not affected in sox4b morphants and, conversely,
that sox4b and gata2a expression is not affected in pit1
mutants. Thus, the sox4b/gata2a cascade acts indepen-
dently of Pit1 to promote gsu and tsh expression in the
pit1-expressing thyrotropes, consistent with the synergis-
tic activation of the Tsh promoter that was described in
mouse (49).
Another cell lineage that is affected in the sox4b mor-
phants is the somatotropes expressing gh. Although less
affected than the thyrotrope and gonadotrope cells, a
clear decrease in gh expression was observed in the sox4b
morphants in zebrafish. In the conditional Gata2 KO
mouse model, Gh expression was normal at birth,
whereas a transient growth retardation was observed in
males between wk 3 and 9 (43). In this model,Gata2 gene
depletion is obtained by expressing the CRE recombinase
in Gsu-expressing cells; thus, the somatotrope cells are
presumably Gata2 positive. However, no Gata2 expres-
sion was observed in mouse somatotropes, and we show
also here no colocalization of gata2a and gh mRNA in
zebrafish, indicating that the effect of Sox4b or Gata2a
depletion on gh expressionmight be cell nonautonomous,
through altering the numbers or properties of other cell
types. The precise significance and mechanism of the
Sox4b/Gata2a regulatory cascade on GH expression will
require further investigation.
Numerous reports have been published on Fsh and Lh
in teleosts. Both hormones are synthesized in gonado-
trope cells in two separate populations exhibiting distinct
patterns of distribution in the zebrafish pituitary (52).
Their expression is low in zebrafish larvae and was only
detectable by RT-PCR at 72 hpf (8), whereas sexual dif-
ferentiation of the gonads was shown to start in 3-wk-old
juveniles (53). Using the more sensitive fluorescent in situ
hybridization, we were able to observe several lh-posi-
tive cells at 72 hpf in control embryos and observed a
clear decrease in the number of these cells in sox4b mor-
phants. qRT-PCR analysis further confirmed the de-
creased expression of both lh and fsh, consistent with
previous studies in mammalian cell culture revealing the
activation of the gonadotropin subunit genes Gsu (50)
and Lh (54) by Gata factors. Our results clearly show
that the Sox4b and Gata2a factors are required for for-
mation of lh- and fsh-expressing cells in developing
zebrafish; thus, they represent to date the only factors
specifically involved in gonadotrope cell differentiation in
zebrafish.
Recently, induction of SOX4 expression by TGF1
was shown in the human HP75 cell line derived from a
silent gonadotropinoma (55), suggesting that Sox4 genes
could be targets for TGF/bone morphogenetic protein
(BMP) signaling pathways. The TGF family member
activin is known to activate gonadotropin expression in
the adult pituitary, whereas inhibin represses this effect
(56). A function for activin in maintaining cellular ho-
meostasis within the pituitary was also proposed. During
pituitary development in the mouse, a crucial role was
demonstrated for BMP, also belonging to the TGF fam-
ily. BMP4 is required early for formation of the Rathke’s
pouch and thus for development of the entire pituitary,
whereas BMP2 exerts a ventralizing effect within the de-
veloping Rathke’s pouch, thus favoring the formation of,
e.g. gonadotropes (57). These observations are consistent
with a role for Sox4b in the transduction of TGF signal-
ing at least in gonadotropes; however, in zebrafish, ma-
nipulation of BMP signaling failed to cause any defect in
pituitary development (58). Thus, at present, the relation-
ship between Sox4 factors and TGF signaling remains
an open question.
Taken together, our results show that the Sry-related
HMG-box transcription factor Sox4b is involved in the
differentiation of thyrotrope and gonadotrope cells and
that this function is mediated by specifically activating
gata2a expression in gsu-expressing pituitary precursor
cells.
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